News & views

A new identity for the expert commercialisation partner at UCL.

The funding will help bring about industry applications sooner.

Trace Neuroscience launches with exclusive license from UCL and $101 million Series A funding to take forward potential new therapeutic for motor neurone disease.

The first-ever patient with the rare immunodeficiency CGD has been successfully treated at Great Ormond Street.

Clinical trial shows test can accurately predict which patients will benefit from chemotherapy.

A pioneering discovery by UCL scientists could transform the fight against diabetic blindness for millions worldwide.

World Savings Day: how EDRAF is empowering the unbanked.

This I-O Converse session saw Dr. Maria Leiloglou, CEO and Co-founder of Enacuity, discuss her journey and challenges to date.

Professor Rajiv Jalan (UCL Institute for Liver and Digestive Health) is a world-leading clinician–scientist in hepatology.

The pioneering developer of handheld robots for minimally-invasive neurosurgery has successfully closed a £1m strategic investment round.

The findings from Queen Square Analytics uncovers two distinct types of multiple scelrosis.

A way to gain deeper insights from records